荣昌生物

- 688331

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2026  2025  2024  2023  2022  2021  2020  2019  2018 
荣昌生物(688331) 利润表
单位:万元
报表日期2026-03-312025-12-312025-09-302025-06-302025-03-31
一、营业总收入65,621.44325,105.11171,983.30109,795.3452,596.86
营业收入65,621.44325,105.11171,983.30109,795.3452,596.86
二、营业总成本69,687.88318,918.70226,841.83154,773.5678,382.45
营业成本11,695.6541,354.0527,059.3417,501.918,803.08
营业税金及附加558.401,635.131,236.76794.26366.43
销售费用27,484.86111,144.4282,265.8952,578.1325,069.62
管理费用8,041.8536,427.5521,562.1314,631.219,018.04
财务费用921.326,482.685,659.314,546.432,236.82
研发费用20,985.80121,874.8789,058.3964,721.6232,888.47
资产减值损失----------
公允价值变动收益36,120.1964,071.3329.375.21--
投资收益-37.26-443.74-468.66-443.39-258.52
其中:对联营企业和合营企业的投资收益-9.3256.3740.84-11.28-12.67
汇兑收益----------
三、营业利润33,017.0372,260.59-53,726.92-44,115.41-24,974.65
加:营业外收入22.0095.0379.7717.8717.03
减:营业外支出189.671,315.771,422.91859.32456.83
其中:非流动资产处置损失----------
四、利润总额32,849.3671,039.85-55,070.06-44,956.87-25,414.45
减:所得税费用48.6574.87------
五、净利润32,800.7170,964.98-55,070.06-44,956.87-25,414.45
归属于母公司所有者的净利润32,800.7170,964.98-55,070.06-44,956.87-25,414.45
少数股东损益----------
六、每股收益
基本每股收益(元/股)0.58001.2900-1.0100-0.8300-0.4600
稀释每股收益(元/股)0.58001.2900-1.0100-0.8300-0.4600
七、其他综合收益33.095,265.214,959.283,001.041,199.30
八、综合收益总额32,833.8076,230.19-50,110.77-41,955.82-24,215.15
归属于母公司所有者的综合收益总额32,833.8076,230.19-50,110.77-41,955.82-24,215.15
归属于少数股东的综合收益总额----------
下载全部历史数据到excel中 返回页顶